NYSE | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 13.65% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 8.37% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.07% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.62% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 5.19% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.85% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.36% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.35% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.89% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 3.81% |
| 7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 3.42% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.12% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.98% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 2.77% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.77% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.68% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.41% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 2.40% |